2024‐03‐12
Aasiyah Rashan edited this page Mar 17, 2024
·
2 revisions
- TC Feedback was that I should narrow the scope of the remaining questions so I finish in time.
- Option 1: Remove the CCHIC analysis and do two target trials instead of three
- Option 2: Keep CCHIC, but do 2 target trials only and remove RQ3.
- Advantage is that I get experience with a high cadence HIC EHR dataset.
- Downsampling was always a slightly contrived addition, and it may not work/be as helpful.
- Agreed that the amount of work required for CCHIC is unknown, but I will have to dedicate time to getting the analysis done, after finishing the prolonged MV work for CCAA.
- We can decide between the options more slowly, as I proceed with the analysis.
- Agreed that we keep the upgrade objectives as per option 1, to match the report.
- Option 1 vs 2 could be a discussion point at the end of the upgrade, but should not be the main focus